Genoray Co., Ltd. (KOSDAQ:122310)
3,115.00
-55.00 (-1.74%)
At close: Oct 23, 2026
Genoray Revenue
Genoray had revenue of 26.62B KRW in the quarter ending June 30, 2026, a decrease of -1.44%. This brings the company's total for the last twelve months to 107.88B, up 2.86% year-over-year. In the year 2025, Genoray had annual revenue of 108.04B with 0.99% growth. That makes Genoray the 24,230th largest company in the world by revenue and 1,398th in South Korea.
Revenue (ttm)
107.88B
Revenue Growth
+2.86%
P/S Ratio
0.37
Revenue / Employee
293.95M
Employees
367
Market Cap
39.66B
Revenue by Geography
- Europe, Middle East, Africa, Oceania (EMEA) 44.83B 41.5%
- South Korea 27.72B 25.7%
- Asia 18.61B 17.2%
- Americas 16.88B 15.6%
Fiscal year ended Dec 31, 2025 See the full Genoray breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 108.04B | 1.06B | 0.99% |
| Dec 31, 2024 | 106.98B | 9.08B | 9.28% |
| Dec 31, 2023 | 97.90B | 15.29B | 18.51% |
| Dec 31, 2022 | 82.60B | 8.31B | 11.19% |
| Dec 31, 2021 | 74.29B | 12.60B | 20.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DRGEM | 109.45B |
| CU Medical Systems | 62.40B |
| JPI Healthcare | 46.86B |
| Hironic | 37.10B |
| SELVAS Healthcare | 31.69B |
| Remed | 27.05B |
| Dynamic solution | 15.11B |
| QuantaMatrix | 3.15B |